Symbol
DNTH on Nasdaq
Investment type
Equity / Common Stock, $0.001 par value
Latest Disclosed Ownership
1.5M shares
Security Ownership
4.7%

TCG Crossover GP II, LLC ownership in Dianthus Therapeutics, Inc. /DE/ Common Stock, $0.001 par value (DNTH)

2025-05-15 - TCG Crossover GP II, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.5M shares of Dianthus Therapeutics, Inc. /DE/ Common Stock, $0.001 par value (DNTH). This represents 4.7% percent ownership of the company.